Our experienced staff, trustees and associates bring their specialist knowledge from a wide range of backgrounds to create interdisciplinary policy solutions to the practical challenges of translating ...
Synthetic data – artificial data that closely mimic the properties and relationships of real data – are not a new concept but technological advances have led to great optimism about their potential ...
Cell-free fetal nucleic acids for non-invasive prenatal diagnosis is the result of a project funded and led by the PHG Foundation. An expert Working Group including GPs, obstetricians, midwives, ...
Transcriptomics is the analysis of the transcriptome, the collection of all ribonucleic acid (RNA) that is present in a sample (a cell, tissue or organ) at a given time. RNA performs many functions ...
The European Union introduced the General Data Protection Regulation (GDPR) in 2018 and it forms part of current UK law. A long and complex piece of legislation, the GDPR governs the processing of ...
Advances in clinical genomics have been enabled by short-read sequencing (SRS) technologies, where the DNA is broken into pieces up to 300 base pairs long. While these technologies have many ...
The UK is a recognised powerhouse for genomic science and medicine. Genomics England’s 100,000 Genomes Project is the largest sequencing project of its kind in the world and, building on these ...
Machine learning is a form of artificial intelligence that uses algorithms to allow a system to learn from data. There are many potential applications of machine learning for health, for example apps ...
Genomic technologies have the potential to transform the management of infectious diseases. In Pathogen Genomics Into Practice we set out a roadmap to converting the power of this exciting new ...
Cancer incidence is increasing worldwide and in the UK it is estimated that 1 in 2 people born after 1960 will be diagnosed with some form of cancer in their lifetime. New tests that analyse ...
The extension by the UK Government of measures for the lawful processing of confidential patient information (CPI) for COVID-19 purposes is likely to have been welcomed by researchers. Introduced ...